146 related articles for article (PubMed ID: 22021696)
1. Outcomes of breast cancer patients with micrometastases and isolated tumor cells in sentinel lymph nodes.
Gloyeske NC; Goreal W; O'Neil M; Connor C; Tawfik OW; Fan F
In Vivo; 2011; 25(6):997-1001. PubMed ID: 22021696
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
3. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
[TBL] [Abstract][Full Text] [Related]
4. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
5. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
6. Outcome of selected breast cancer patients with micrometastasis or isolated tumor cells in sentinel node biopsy and no completion axillary lymph node dissection.
Meretoja TJ; Vironen JH; Heikkilä PS; Leidenius MH
J Surg Oncol; 2010 Sep; 102(3):215-9. PubMed ID: 20740577
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
8. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells.
Pepels MJ; de Boer M; Bult P; van Dijck JA; van Deurzen CH; Menke-Pluymers MB; van Diest PJ; Borm GF; Tjan-Heijnen VC
Ann Surg; 2012 Jan; 255(1):116-21. PubMed ID: 22183034
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance.
Ahmed SS; Thike AA; Iqbal J; Yong WS; Tan B; Madhukumar P; Ong KW; Ho GH; Wong CY; Tan PH
J Clin Pathol; 2014 Mar; 67(3):243-50. PubMed ID: 24218025
[TBL] [Abstract][Full Text] [Related]
11. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining.
Imoto S; Ochiai A; Okumura C; Wada N; Hasebe T
Eur J Surg Oncol; 2006 Dec; 32(10):1175-9. PubMed ID: 16979316
[TBL] [Abstract][Full Text] [Related]
12. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
Krauth JS; Charitansky H; Isaac S; Bobin JY
Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
[TBL] [Abstract][Full Text] [Related]
14. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
15. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
16. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
Roumen RM; Kuijt GP; Liem IH; van Beek MW
Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
[TBL] [Abstract][Full Text] [Related]
17. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
18. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
19. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
20. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases.
Toussaint A; Nogaret JM; Veys I; Hertens D; Noterman D; De Neubourg F; Larsimont D; Bourgeois P
Breast J; 2011; 17(4):337-42. PubMed ID: 21752137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]